[1] Gould M K, Lillington GA. Strategy and cost in investigating solitary pulmonary nodules[J]. Thorax, 1998, 53(Suppl 2):532~537.
[2] Gambhir SS, Shepherd JE, Shah BD, et al. Analytical decision model for the cost-effective management of solitary pulmonary nodules[J]. J Clin Oncol, 1998, 16(6):2113~2125.
[3] Colman RE. PET in lung cancer[J]. J Nucl Med, 1999, 40(5):814~819.
[4] Prauer HW, Weber WA, Romer W, et al. Controlled prospective study of poistron emission tomography using the glucose analogue[18F] of luorodeoxyglucose in the evaluation of pulmonary nodules[J]. Brit J Sur, 1998, 85:1506~1511.
[5] Fletcher JW, Lowe VJ. Is PET ready for prime time?[J]. J Nucl Med, 1996, 37(6):948~949.
[6] Lowe VJ, Fletcher JW, Gobar L, et al. Prospective investigation of positron emission tomography in lung nodules[J]. J Clin Oncol, 1998, 16(3):1075~1084.
[7] Dholakia S, Rappaport DC. The solitary pulmonary nodule:Is it malignant or benign?[J]. Postgrad Med, 1996, 99:246~250.